PHARMA FIDELMED
0762.489.086 · rovalta.com · 25/09/2026
PHARMA FIDELMED
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPHARMA FIDELMED is a Private limited company incorporated in 2021. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Gent. It employs on average 2,6 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0762.489.086
- Incorporation
- 26/01/2021
- Legal form
- Private limited company
- Registered office
- Waalkens 11 box C
9030 Gent · FlandreSee on map - Contributed capital
- 20 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 2,6 ETP
Joint committees (2)
- 313
- 3130
Financials
Source · NBB, 4 filingsTrend over 4 financial years
| 2025 | 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Gross margin | 301,9 k € | -16.9% | 363,5 k € | +569% | -77,5 k € | -56.0% | -49,7 k € |
| EBITDA | 124,7 k € | -40.8% | 210,8 k € | +205% | -201,5 k € | -65.5% | -121,8 k € |
| Operating result | -64,3 k € | -367% | 24,1 k € | +111% | -217,1 k € | -44.3% | -150,5 k € |
| Net result | -119,7 k € | -214% | -38,1 k € | +85.1% | -255,2 k € | -65.8% | -153,9 k € |
| Balance sheet | |||||||
| Equity | -546,8 k € | -28.0% | -427,1 k € | -9.8% | -389,1 k € | -191% | -133,9 k € |
| Total assets | 2 M € | +19.7% | 1,7 M € | +20.9% | 1,4 M € | +819% | 153 k € |
| Cash | 6,2 k € | -72.2% | 22,1 k € | +21.2% | 18,3 k € | +506% | 3 k € |
| Debts | 2,6 M € | +21.4% | 2,1 M € | +18.5% | 1,8 M € | +526% | 286,9 k € |
| Other | |||||||
| Workforce | 2,6 ETP | +18.2% | 2,2 ETP | +29.4% | 1,7 ETP | +70.0% | 1,0 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20253 active · 7 ended
Active mandates
Ended mandates
Other companies at this address
Waalkens 11 9030 Gent| Company | CBE no. |
|---|---|
FIDELMED● Active | 0698.912.120 |
Fidelmed Group● Active | 1031.653.693 |
MEDISALE● Active | 0432.382.547 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 26/01/2021 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
| Length of the financial year | 12 months | 12 months | 12 months | 24 months |
| Filing date | 27/07/2026 | 30/09/2025 | 25/11/2024 | 20/07/2023 |
| General meeting | 24/06/2026 | 26/09/2025 | 18/11/2024 | 20/06/2023 |
| Currency of the financial year | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 4 filingsValuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20253 active · 7 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-119,7 k €↓
- 2024Annual accounts 2024-38,1 k €↑
- 2023Annual accounts 2023-255,2 k €↓
- 2022Annual accounts 2022-153,9 k €
- 26/01/2021IncorporationPrivate limited company